According to a report by the Manila Times on August 13, the Philippine Smoke-Free Movement (PSFM) is calling on lawmakers to review the e-cigarette regulation law following the first reported death related to e-cigarettes.
Rizal Duro, the national coordinator for PSFM, mentioned during a forum on Monday (12th) a recent report from the Ministry of Health. The report stated that a 22-year-old athlete died from lung damage associated with e-cigarette use (Evali).
Du Luo pointed out that the athlete is in good physical health, with no underlying medical conditions, but has been using e-cigarettes daily for the past two years.
The coordinator cited government data and expressed regret over the sharp increase in the number of teenagers addicted to e-cigarettes.
A recent global survey on tobacco use among teenagers revealed that one in eight children aged 13 to 15 are already smoking, with one in seven preferring e-cigarettes.
Ma. Aurora Quilala, Deputy Executive Director of the Philippine Legislators' Committee on Population and Development (PLCPD), stated that the same data also indicates a failure in "our society and the entire country" in fully protecting the rights and well-being of young people, especially in terms of their health.
Quilala and Duro are both calling for an immediate review of Republic Act 11900 and are requesting that the age limit for the sale and use of e-cigarettes be restored to 21 years old.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
